Mr. Richard has served as a member of our Board of Directors since August 2013,
Mr. Richard is an operating partner and non-executive director for Phase4 Partners. He is also co-founder and Head of Corporate Development for Mereo BioPharma Ltd, a pharmaceutical spin-out launched by Phase4 Partners in 2015. From 2005 until 2015 Mr. Richard was also a partner with Georgia Venture Partners, a seed venture capital firm focused on the biotechnology industry. Earlier in his career he headed business development for the public companies SEQUUS Pharmaceuticals, VIVUS, and Genome Therapeutics, and was CEO and co-founder of Impath (subsequently acquired by Genzyme). Mr. Richard currently serves as a director of Catalyst Biosciences, Inc.
Mr. Richard received his M.B.A. from the Harvard Business School and a B.S. from Stanford University.